Organogenesis Holdings (ORGO) Total Debt (2017 - 2024)

Organogenesis Holdings' Total Debt history runs 8 years deep, the most recent figure standing at $62.1 million for Q3 2024.

• On a quarterly basis, Total Debt fell 8.11% year-over-year to $62.1 million in Q3 2024; TTM through Sep 2024 was $62.1 million, a 8.11% decrease from a year earlier, with the FY2023 full-year figure at $66.2 million, down 6.41% from the prior year.
• Total Debt fell to $62.1 million in Q3 2024 per ORGO's latest filing, from $63.5 million in the prior quarter.
• Across five years, Total Debt topped out at $92.5 million in Q2 2021 and bottomed at $11.7 million in Q1 2020.
• The 5-year median for Total Debt is $67.6 million (2023), against an average of $64.4 million.
• Across the five-year window, Total Debt sank 74.07% in 2020 and surged 412.14% in 2021, its largest moves.
• Year by year, Total Debt stood at $59.7 million in 2020, then rose by 22.97% to $73.4 million in 2021, then decreased by 3.62% to $70.8 million in 2022, then fell by 6.41% to $66.2 million in 2023, then slipped by 6.21% to $62.1 million in 2024.
• Per Business Quant, the three latest ORGO Total Debt figures stand at $62.1 million (Q3 2024), $63.5 million (Q2 2024), and $64.9 million (Q1 2024).